Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Hancock Jaffe Laboratories Inc (HJLI)

Hancock Jaffe Laboratories Inc (HJLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
enVVeno Medical Corporation Successfully Completes Rebranding ACCESS Newswire - Fri Oct 1, 2021

Company Now Trading Under Ticker Symbol "NVNO" IRVINE, CA / ACCESSWIRE / October 1, 2021 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care...

HJLI : 10.38 (-1.98%)
enVVeno Medical Corporation Successfully Completes Rebranding ACCESS Newswire - Fri Oct 1, 2021

Company Now Trading Under Ticker Symbol "NVNO" IRVINE, CA / ACCESSWIRE / October 1, 2021 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care...

HJLI : 10.38 (-1.98%)
Hancock Jaffe to Participate in the Duologue Series Virtual Webinar Hosted by Ladenburg Thalmann ACCESS Newswire - Fri Sep 24, 2021

Live webinar followed by Q&A on Monday, September 27th at 1:00 PM ET with Robert Berman Chief Executive Officer of Hancock Jaffe Laboratories IRVINE, CA / ACCESSWIRE / September 24, 2021 / Hancock Jaffe...

HJLI : 10.38 (-1.98%)
Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development Pipeline on Venous Disease Programs ACCESS Newswire - Tue Sep 21, 2021

- Hancock Jaffe changing name to enVVeno Medical Corporation and ticker symbol to NASDAQ: NVNO, effective October 1, 2021 - - Development strategy to focus on venous disease and advancement of the VenoValve®...

HJLI : 10.38 (-1.98%)
Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021 ACCESS Newswire - Wed Sep 15, 2021

Conference call with live video webcast to be held on Tuesday, September 21st at 4:30 p.m. ET IRVINE, CA / ACCESSWIRE / September 15, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe"...

HJLI : 10.38 (-1.98%)
Hancock Jaffe Presents New Positive Two-Year VenoValve Data at the Society for Vascular Surgery Annual Meeting ACCESS Newswire - Thu Aug 19, 2021

Two-year VenoValve® data shows average improvements in reflux, disease manifestations and pain, of 63%, 60%, and 93%, respectively Patients with venous ulcers who experienced dramatic ulcer healing had...

HJLI : 10.38 (-1.98%)
FDA Grants Breakthrough Device Designation Status for Hancock Jaffe's VenoValve ACCESS Newswire - Tue Aug 3, 2021

- Goal of FDA Breakthrough Device Program is to speed up development by giving priority to devices that treat life-threatening or irreversibly debilitating conditions - Company preparing to begin SAVVE...

HJLI : 10.38 (-1.98%)
First U.S. Patent Issues on Hancock Jaffe VenoValve ACCESS Newswire - Wed Apr 7, 2021

IRVINE, CA / ACCESSWIRE / April 7, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the United States...

HJLI : 10.38 (-1.98%)
Hancock Jaffe Receives IDE Approval To Begin VenoValve U.S. Pivotal Trial ACCESS Newswire - Mon Apr 5, 2021

IRVINE, CA / ACCESSWIRE / April 5, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the U.S. Food and...

HJLI : 10.38 (-1.98%)
Hancock Jaffe Submits IDE Application to FDA for VenoValve U.S. Pivotal Trial ACCESS Newswire - Mon Mar 8, 2021

IRVINE, CA / ACCESSWIRE / March 8, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has submitted...

HJLI : 10.38 (-1.98%)

Barchart Exclusives

This ETF Could Be the Trade of the Year If Long-Term Rates Drop Barchart - 3 minutes ago
As a guy who looks at charts almost daily, I can’t help but notice when major trend reversals start shaping up. I think I see one, and this ETF should be on your watch list. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.